Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.08
+0.13 (2.63%)
At close: Apr 28, 2026, 4:00 PM EDT
5.00
-0.08 (-1.57%)
After-hours: Apr 28, 2026, 6:02 PM EDT

Company Description

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.

It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services.

It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals.

The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025.

The company was founded in 2014 and is headquartered in New York, New York.

Strata Critical Medical, Inc.
Strata Critical Medical logo
Country United States
Founded 2014
Industry Medical Care Facilities
Sector Healthcare
Employees 327

Contact Details

Address:
31 Hudson Yards, 14th Floor
New York, New York 10001
United States
Phone 585 301 1762
Website stratacritical.com

Stock Details

Ticker Symbol SRTA
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001779128
ISIN Number US0926671043
Employer ID 84-1890381
SIC Code 8000

Key Executives

Name Position
Louis R. Verdetto Chief Executive Officer of Clinical Services
Scott M. Wunsch Chief Executive Officer of Logistics Services
William A. Heyburn Co-Chief Executive Officer, Chief Financial Officer and Director
Melissa M. Tomkiel J.D. Co- Chief Executive Officer, General Counsel, Corporate Secretary and Director
Amir M. Cohen Chief Accounting and Integration Officer
Mathew Schneider C.F.A. Chief Financial Officer of Clinical Services and Vice President of Finance and Investor Relations
Keith Trepanier Chief of Safety
Dr. Scott Silvestry Chief Surgeon

Latest SEC Filings

Date Type Title
Apr 16, 2026 SCHEDULE 13D/A Filing
Apr 14, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 14, 2026 DEF 14A Other definitive proxy statements
Apr 8, 2026 SCHEDULE 13D/A Filing
Apr 7, 2026 SCHEDULE 13D Filing
Mar 3, 2026 10-K Annual Report
Mar 3, 2026 8-K Current Report
Feb 5, 2026 8-K Current Report
Jan 21, 2026 SCHEDULE 13G Filing
Dec 3, 2025 8-K Current Report